Here’s Pfizer / BioNTech’s response to the half-dose vaccine: no evidence of efficacy



[ad_1]

Portfolio Signature for Christmas too.

Key analysis and exclusive content under the tree. You can even give a last-minute gift to someone with a one-year Portfolio Signature subscription. And if you buy an annual subscription for multiple friends, friends and family at the same time, you can also get a quantity discount. So in addition to being a useful holiday gift, it can even support the production of quality inexpensive content. Know more

“The safety and efficacy of the vaccine have not been studied at different dosing time frames; most subjects received the second dose of the vaccine at the intervals specified in the study,” passed.

We have no evidence that protection is maintained beyond 21 days after the first dose.

highlighted the joint statement.

For complete protection, you must adhere to the maximum interval of 42 days for the Pfizer / BioNTech vaccine.

The EMA, which authorized the vaccination on December 21, reported this Monday.

Germany on Monday considered delaying the administration of the second vaccine dose by studying the British example, while Denmark decided to extend the interval between the administration of the two vaccines to six weeks.

Spanish Health Minister Illa Salvador said Monday that the Spanish public health authority would deliver two doses of the BioNTech / Pfizer vaccine within a period specified by the manufacturers.

In the UK, it was decided that the doses originally reserved for the second dose would also be given as the first dose, so that as many people as possible would receive it as soon as possible. The second dose is given 12 weeks later.

Cover image: Getty Images



[ad_2]